Company Name or Ticker Symbol
Search for other Categories
Casi Pharmaceuticals, Inc.  (CASI)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs


Deterioration in Earnings, Revenues Unchanged

decrease font size NEWS BETA Increase font size

Casi Pharmaceuticals, Inc announced forth quarter 2016 operating income of $3.831987 millions

For the forth quarter 2016 Casi Pharmaceuticals, Inc income fell by -11.06 % of $0.12 per share compare to $0.14 a year ago and eps remained unchanged from $0.12 per share from the previous quarter.

Sales remained unchanged to $-0 millions from $-0 millions in the same quarter a year ago and sequentially from $-0 millions.

Net income of $4 millions in the forth quarter 2016 fell by -45.9 % from $7 millions in the corresponding period a year before. Casi Pharmaceuticals, Inc also emphasized it's improving profit margins, where net margin rose to -8171.57% in forth quarter 2016, and operating margin edged up to -8031.5%.

Casi Pharmaceuticals, Inc reported net loss of $-7 millions and Sales of $0 millions for the fiscal year 2015.

Biotechnology & Drugs Company has decreased it's loss per share to $-0.22 from $-0.92 in the previous fiscal year, while by 101.09 % from $0 millions a year ago.
Other CASI's Earnings Reports

Casi Pharmaceuticals reported forth quarter 2015 earnings

Casi Pharmaceuticals reported second quarter 2015 earnings

Casi Pharmaceuticals reported first quarter 2015 earnings

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com